Uncategorized

Introduction: Biomerica, Inc. Reports Fiscal 2023 Financial Results and Progress of inFoods® IBS Program Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, announced its fiscal 2023 financial results and the successful advancement of its inFoods® IBS pilot program. The company reported net sales of $5.3 million for the fiscal year ended May…

Introduction: Aemetis, Inc. Announces Sale of D3 RINs and LCFS Credits Aemetis, Inc. (NASDAQ: AMTX), a leading renewable natural gas and renewable fuels company, has recently made significant strides in generating revenue through the sale of D3 Renewable Identification Number credits (RINs). The company’s first commercial D3 RIN transaction under the federal Renewable Fuel Standard…

Introduction: Welcome to today’s stock update! In this blog post, we will be covering the latest financial results of some of the companies I own stocks in. It’s always exciting to see how these companies are performing, and today we have some particularly notable announcements. From record-breaking revenues to quarterly financial results, let’s dive into…

Welcome to today’s blog post where we will be discussing the latest updates and financial results of the stocks I own. In this post, we will be covering the second quarter results of Abercrombie & Fitch Co., the fiscal 2024 second quarter results of Dycom Industries, Inc., the third quarter results of Toll Brothers for…

Introduction: SAB Biotherapeutics Reports Promising Results and Advances in Immunotherapy Platform SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company specializing in immunotherapy, recently announced their financial results for the second quarter of 2023, along with an exciting company update. This update highlights their commitment to advancing transformative immunotherapies, focusing on Type 1 Diabetes through their…

Introduction: Rail Vision Ltd. Reports Strong Q2 Results and Continues to Revolutionize Railway Safety Rail Vision Ltd. (Nasdaq: RVSN), a development stage technology company specializing in railway safety and data solutions, announced its financial results for the second quarter ended June 30, 2023. The company reported completing a series of transactions that raised $6 million,…

Introduction: NANO-X IMAGING LTD Reports Progress towards Global Supply Chain Development NANO-X IMAGING LTD, an innovative medical imaging technology company, recently released its second-quarter results and provided a business update. The company ended the second quarter of 2023 with $80.3 million in cash, cash equivalents, restricted cash, and marketable securities. One significant highlight of the…

Introduction: Welcome to today’s stock update! In this blog post, we will be discussing the latest events and financial results of the stocks I own. We’ll explore the impressive growth of LiveOne’s Slacker Radio, Progressive’s July 2023 results, Kamada’s strong second quarter, Crown Crafts’ financial results for the first quarter of Fiscal 2024, and dLocal’s…

Introduction: OKYO Pharma Limited Announces Positive Developments with Flagship Drug OK-101 to Treat Dry Eye Disease OKYO Pharma Limited (NASDAQ: OKYO), a leading ophthalmology-focused bio-pharmaceutical company, has reported financial results for the twelve months ended March 31, 2023, along with an update on its lead program, OK-101. The company’s CEO, Gary Jacob, expressed his satisfaction…

Welcome back to our daily stock blog post! Today, we have some exciting news to share about the recent financial results and corporate updates from several companies in our portfolio. In this post, we will be discussing the second quarter 2023 reports and announcements from Reading International, The Metals Company, Inter&Co, Atossa Therapeutics, and Vaccinex….